ClinicalTrials.govpublic full text
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
hepatitis c, chronic, infection, triple therapy, tmc435, simeprevir, pegylated interferon alfa-2a (pegifnα-2a), ribavirin (rbv), pegasys, copegus, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995022
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.